Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Issue #31, June 2019
A plaintiff whose $55 million talcum powder ovarian cancer verdict was tossed on jurisdiction grounds has re-filed her complaint directly into the New Jersey federal court overseeing the national multidistrict litigation docket for talcum powder claims.
Johnson & Johnson and Johnson & Johnson Consumer Inc. have filed a reply brief backing their efforts to fix venue for thousands of claims it says is related to Imerys Talc America’s bankruptcy, maintaining that its attempt to move the cases is not a delay tactic and that “effectuates the sound policies that motivated Congress’s enactment of 28 U.S.C. § 157(b)(5).”
Plaintiffs with cases pending in the national multidistrict litigation docket for talcum powder claims have opposed Johnson & Johnson’s recent efforts to exclude general causation opinions of plaintiff experts, maintaining that the question at this juncture of the litigation is not whether the experts were right in their conclusions, but rather whether the experts were qualified to offer their opinions.
Johnson & Johnson and Johnson & Johnson Consumer Inc. have challenged a motion to exclude opinions of their molecular biologists proffered in the national talcum powder multidistrict litigation docket, maintaining that the plaintiffs have “misperceived” the nature of the expert testimony.
Johnson & Johnson and Johnson & Johnson Consumer Inc. have filed their brief in their appeal of a $110 million verdict in a talcum powder ovarian cancer case, asserting a number of assignments of error, including a lower court decision rejecting personal jurisdiction challenges.
N.Y. Jury Adds $300 Million in Punitive Damages to Earlier $25 Million Award in Asbestos Cosmetic Talc Trial Against J&J
A New York jury has added $300 million in punitive damages to its earlier $25 million compensatory damage verdict, finding that Johnson & Johnson’s misconduct caused the plaintiff to develop mesothelioma from using talcum powder products, HarrisMartin is reporting.
Issue #30, May 2019
A South Carolina jury has found in favor of Johnson & Johnson on claims that a woman’s cancer was caused by her use of the company's talcum powder.
A New York jury has awarded $25 million in compensatory damages at the conclusion of an asbestos cosmetic talcum powder trial against Johnson & Johnson and answered affirmatively that the plaintiffs are entitled to punitive damages, HarrisMartin Publishing is reporting.
A Delaware court has ruled that Johnson & Johnson has not established that provisional transfer is warranted of “essentially every talc case pending against it,” rejecting the defendant’s efforts to move all state court talcum powder claims to the court overseeing Imerys Talc America’s bankruptcy petition.
Issue #29, April 2019
Talcum powder ovarian cancer claims pending in Georgia state court that were scheduled for a July trial are among the thousands that were removed to federal court as part of an effort by Johnson & Johnson to have the cases linked to Imerys Talc America’s bankruptcy proceedings.